Table 2.
Area | Study | Country | N | Mean IS total score | SD | n | High IS (%) | ||
---|---|---|---|---|---|---|---|---|---|
Europe | SMI | Evans-Lacko51 | Multi-site | 1835 | 2.2 | 0.5 | - | - | |
Grambal169 | Czech Republic | 184 | 2.19 | 0.5 | - | - | |||
Rusch58 | Switzerland | 186 | 1.9 | 0.6 | - | - | |||
Xu57 | Switzerland | 141 | 1.91 | 0.61 | - | - | |||
Kamaradova170 | Czech Republic | 332 | 2.10 | 0.5 | - | - | |||
Bradstreet45 | UK | 272 | 2.2 | 0.49 | - | - | |||
Krajewski33 | Multi-site | 786 | 2.29 (1.96–2.71) | 0.5 | 786 | 33% (15.2%–57.4%) | |||
Dubreucq93 | France | 738 | 2.20 | 0.51 | 738 | 31.2% | |||
Oexle96 | Switzerland | 222 | 2.10 | 0.55 | - | - | |||
Rusch107 | Switzerland | 116 | 2.15 | 0.54 | - | - | |||
Szczesniak171 | Poland | 114 | 2.23 | 0.5 | - | - | |||
Weighted total | 4926 | 2.18 | 0.26 | 1524 | 32% | ||||
Schizophrenia | Brohan9 | Multi-site | 1129 | 2.40 (2.0–2.97) | 0.56 | 1129 | 41.7% | ||
Vidovic126 | Croatia | 149 | 2.13 | 0.93 | 149 | 22.8% | |||
Sibitz172 | Austria | 157 | 2.09 | 0.67 | - | - | |||
Galderisi173 | Italia | 921 | 2.1 | 0.5 | - | - | |||
Rossi174 | Italia | 910 | 2.2 | 0.44 | - | - | |||
Aukst-Margetic81 | Croatia | 117 | 2.13 | 0.44 | - | - | |||
Hofer30 | Austria | 52 | 2.01 | 0.51 | - | - | |||
Bouvet175 | France | 62 | 2.23 | 0.46 | - | - | |||
Vrbova176 | Czech Republic | 197 | 2.18 | 0.46 | - | - | |||
Surmann177 | Germany | 80 | 2.12 | 0.47 | - | - | |||
Dubreucq93 | France | 466 | 2.18 | 0.51 | 466 | 29.8% | |||
Holubova178 | Czech Republic | 103 | 2.20 | 0.47 | - | - | |||
Szczesniak171 | Poland | 51 | 2.19 | 0.5 | - | - | |||
Uhlmann179 | Germany | 23 | 2.0 | 0.5 | - | - | |||
Vrbova176 | Czech Republic | 197 | 2.18 | 0.47 | - | - | |||
Switaj83 | Poland | 110 | 2.39 | 0.53 | - | - | |||
Weighted total | 4724 | 2.21 | 0.27 | 1744 | 36.9% | ||||
Bipolar disorders/MDD | Brohan10 | Multi-site | 577 | 1.94 BD | 1.97 | 0.87 | 1182 | 21.7% | |
603 | 2.11 MDD | ||||||||
Bipolar disorders | Post180 | Austria | 60 | 1.9 BD | 0.57 | - | - | ||
Dubreucq93 | France | 117 | 2.2 | 0.53 | 117 | 29.9% | |||
Quenneville181 | Switzerland | 69 | 2.27 | 0.5 | - | - | |||
Szczesniak171 | Poland | 19 | 2.39 | 0.5 | - | - | |||
MDD | Lanfredi182 | Multi-site | 516 | 2.2 | 0.5 | - | - | ||
Dubreucq93 | France | 27 | 2.29 | 0.56 | 27 | 40.7% | |||
Holubova178 | Czech Republic | 80 | 1.96 | 0.42 | - | - | |||
Prasko95 | Czech Republic | 72 | 2.36 | 0.49 | - | - | |||
Szczesniak171 | Poland | 42 | 2.46 | 0.6 | - | - | |||
Weighted total | BD MDD |
842 | 2.01 | 0.60 | 1326 | 22.7% | |||
1340 | 2.16 | 0.47 | |||||||
Anxiety disorders | Ociskova183 | Czech Republic | 109 | 2.24 | 0.49 | - | - | ||
Grambal169 | Czech Republic | 37 | 1.98 | 0.54 | |||||
Dubreucq93 | France | 19 | 2.35 | 0.56 | 19 | 42.1% | |||
OCD | Moritz184 | Germany | 50 | 1.99 | 0.48 | - | - | ||
Weighted total | - | 215 | 2.14 | - | 19 | 42.1% | |||
BPD | Grambal169 | Czech Republic | 35 | 2.45 | 0.50 | - | - | ||
Dubreucq93 | France | 64 | 2.36 | 0.47 | 64 | 43.8% | |||
Quenneville181 | Switzerland | 39 | 2.56 | 0.66 | - | - | |||
Personality disorder | Kamaradova170 | Czech Republic | 17 | 2.37 | 0.58 | - | - | ||
Weighted total | - | 155 | 2.43 | - | 64 | 43.8% | |||
North America | SMI | Livingston36 | Canada | 91 | 2.13 | 0.38 | 91 | 10% | |
Livingston37 | Canada | 71 | 2.10 | 0.35 | 71 | 9% | |||
Livingston43 | Canada | 94 | 2.22 | 0.49 | 94 | 23.4% | |||
West13 | USA | 144 | 1.72 | 0.57 | 144 | 36.1% (31%–41%) | |||
Ritscher-Boyd112 | USA | - | - | - | 82 | 28% | |||
Ritscher-Boyd185 | USA | 149 | 2.19 | 0.52 | 149 | 24.8% | |||
Drapalski186 | USA | 100 | 2.3 | 0.4 | 100 | 35% | |||
Harris38 | USA | 235 | 2.31 | 0.47 | 235 | 37% | |||
Chronister187 | USA | 101 | 2.2 | 0.45 | 101 | 25% | |||
Kira188 | USA | 330 | 2.16 | 0.72 | 330 | 40.1% | |||
Tomar189 | USA | 108 | 2.31 | 0.5 | 108 | 40.7% | |||
Pearl105 | USA | 319 | 2.11 | 0.53 | - | - | |||
Jahn190 | USA | 516 | 2.25 | 0.49 | - | - | |||
Villotti191 | USA | 170 | 1.95 | 0.47 | - | - | |||
Weighted total | - | 2428 | 2.16 | 1505 | 31.4% | ||||
Schizophrenia | Firmin192 | USA | - | - | - | 111 | 36.5% (25%–45%) | ||
O’Connor133 | USA | - | - | - | 353 | 50% | |||
Link193 | USA | - | - | - | 65 | 26.2% | |||
Lysaker101 | USA | 70 | 2.36 | 0.54 | |||||
Weighted total | - | 70 | 2.36 | 0.29 | 529 | 44.2% | |||
Bipolar disorders | Howland42 | USA | 115 | 2.22 | 0.48 | 115 | 26% | ||
Bassirnia194 | USA | 112 | 1.94 | 0.47 | - | - | |||
Weighted total | 227 | 2.08 | 0.22 | ||||||
South America | Schizophrenia | Caqueo-Uritzar34 | Multi-site | 253 | 2.3 | 0.54 | 253 | 38.6% (28.6%–48.7%) | |
Weighted total | 253 | 2.3 | 0.29 | ||||||
Australia | Schizophrenia | Hill195 | Australia | 60 | 2.56 | 0.49 | - | - | |
Weighted total | 60 | 2.56 | 0.24 | ||||||
South Asia | SMI | Grover196 | India | 1,403 | 2.29 | 0.47 | 1403 | 29.4% | |
Maharjan197 | Nepal | - | - | - | 180 | 52% | |||
Weighted total | - | 1403 | 2.29 | 0.22 | 1583 | 28.6% | |||
Schizophrenia | Grover196 | India | 707 | 2.37 | 0.51 | 707 | 37.9% | ||
Singh198 | India | 100 | 2.3 | 0.40 | 100 | 29% | |||
Pal199 | India | 32 | 2.74 | 0.40 | - | - | |||
Weighted total | - | 839 | 2.37 | 0.24 | 807 | 36.8% | |||
Bipolar disorders | Grover196 | India | 344 | 2.23 | 0.38 | 344 | 20.6% | ||
Pal199 | India | 59 | 2.25 | 0.38 | - | - | |||
Grover200 | India | 185 | 2.33 | 0.43 | 185 | 28% | |||
Weighted total | - | 588 | 2.26 | 0.15 | 529 | 23.2% | |||
MDD | Grover196 | India | 352 | 2.19 | 0.45 | 352 | 21% | ||
Sahoo201 | India | 107 | 2.39 | 0.57 | 107 | 40.1% | |||
Weighted total | - | 459 | 2.23 | 0.23 | 459 | 25.5% | |||
Anxiety disorders | Pal199 | India | 30 | 1.97 | 0.37 | - | - | ||
South-East Asia | SMI | Picco202 | Singapore | 280 | 2.37 | 0.54 | 280 | 43.6% | |
Ho97 | China | 136 | 2.3 | 0.6 | 136 | 36.8% | |||
Young35 | China | 474 | 2.42 (2.34–2.50) | 0.52 | 474 | 43.5% (38.3%–49.5%) | |||
Kim39 | South Korea | 160 | 2.06 | 0.36 | 160 | 8.1% | |||
Kao40 | Taiwan | 251 | 2.26 | 0.51 | 251 | 50% | |||
Weighted total | - | 1301 | 2.32 | 0.26 | 1301 | 39.7% | |||
Schizophrenia | Lv138 | China | 95 | 2.17 | 0.38 | 95 | 20% | ||
Hsiao61 | Taiwan | 111 | 2.33 | 0.53 | 111 | 27% | |||
Lien76 | Taiwan | 170 | 2.36 | 0.52 | 170 | 39.4% | |||
Kao40 | Taiwan | 151 | 2.42 | 0.44 | 151 | 51% | |||
Li139 | China | 384 | 2.30 | 0.39 | - | - | |||
Hofer30 | Japan | 60 | 2.16 | 0.42 | - | - | |||
Ran127 | China | 232 | 2.46 | 0.28 | - | - | |||
Mak67 | China | 162 | 2.34 | 0.61 | - | - | |||
Shin88 | South Korea | 70 | 2.11 | 0.53 | - | - | |||
Pribadi203 | Indonesia | 300 | 2.5 | 0.94 | 300 | 34% | |||
Picco202 | Singapore | 74 | 2.41 | 0.52 | |||||
Kim204 | South Korea | 123 | 2.15 | 0.50 | - | - | |||
Lu205 | China | 92 | 2.11 | 0.45 | - | - | |||
Park206 | South Korea | 321 | 2.51 | 0.65 | - | - | |||
Weighted total | - | 2345 | 2.36 | 0.32 | 827 | 32.4% | |||
Bipolar disorder | Ran127 | China | 39 | 2.36 | 0.30 | - | - | ||
Weighted total | 2.36 | 0.09 | |||||||
MDD | Picco202 | Singapore | 74 | 2.44 | 0.55 | - | - | ||
Woon207 | Malaysia | 99 | 2.0 | 0.6 | 99 | 23.2% | |||
Ran127 | China | 182 | 2.43 | 0.28 | - | - | |||
Weighed total | 355 | 2.31 | 0.20 | 99 | 23.2% | ||||
Anxiety Disorders OCD |
Picco202 | Singapore | 71 | 2.23 | 0.56 | - | - | ||
Picco202 | Singapore | 61 | 2.41 | 0.49 | - | - | |||
Weighted total | - | 132 | 2.31 | ||||||
Middle East | SMI | Ghanean208 | Iran | - | - | - | 138 | 39% | |
Tanriverdi209 | Turkey | 217 | 2.59 | 0.33 | - | - | |||
Hasson-Ohayon210 | Israel | 107 | 2.28 | 0.49 | - | - | |||
Korkmaz211 | Turkey | 224 | 2.53 | 0.48 | - | - | |||
Weighted total | 548 | 2.50 | 0.18 | ||||||
Schizophrenia | Sarisoy41 | Turkey | 109 | 2.17 | 0.51 | 109 | 29.4% | ||
Çapar212 | Turkey | 250 | 2.76 | 0.37 | - | - | |||
Olçun213 | Turkey | 76 | 2.51 | 0.55 | - | - | |||
Yilmaz214 | Turkey | 63 | 2.63 | 0.49 | - | - | |||
Yildirim94 | Turkey | 200 | 2.74 | 0.46 | - | - | |||
Tanriverdi209 | Turkey | 46 | 2.54 | 0.25 | |||||
Weighted total | - | 744 | 2.61 | 0.32 | 109 | 29.4% | |||
Bipolar disorders | Sarisoy41 | Turkey | 118 | 2.10 | 0.46 | 118 | 18.5% | ||
Cerit215 | Turkey | 80 | 2.12 | 0.39 | - | - | |||
Sadighi216 | Iran | 126 | 1.90 | 0.87 | 126 | 27.6% | |||
Tanriverdi209 | Turkey | 63 | 2.52 | 0.32 | - | - | |||
Weighted total | - | 387 | 2.10 | 0.35 | 244 | 19.2% | |||
Africa | SMI | Adewuya217 | Nigeria | - | - | - | 340 | 21.6% | |
Girma53 | Ethiopia | 422 | 2.32 | 0.30 | 422 | 25.1% | |||
Ibrahim55 | Nigeria | - | - | - | 370 | 22.5% | |||
Asrat218 | Ethiopia | - | - | - | 317 | 32.1% | |||
Weighted total | 422 | 2.32 | 0.09 | 1449 | 25.1% | ||||
Schizophrenia | Mosanya125 | Nigeria | 256 | 1.94 | 0.68 | 256 | 18.8% | ||
Fadipe219 | Nigeria | 370 | 2.09 | 0.43 | 370 | 16.5% | |||
Assefa220 | Ethiopia | - | - | - | 212 | 46.7% | |||
Bifftu124 | Ethiopia | - | - | - | 411 | 48.6% | |||
Weighted total | - | 626 | 2.03 | 0.29 | 1249 | 32.6% |
Note: MDD, Major Depressive Disorder; OCD, Obsessive Compulsive Disorder; BPD, Borderline Personality Disorder; SMI, Severe Mental Illness. Mean Internalized Stigma refers to ISMI mean total score. High Internalized Stigma refers to the proportion of patients with ISMI > 2.5 or above the midpoint on other scales. Bold faces represents the total sample and the weighted means and proportions.